SlideShare a Scribd company logo
GLOBAL POLIO UPDATES, POLIO END
GAME AND HEALTH SYSTEMS
STRENGTHENING
CGPP-ADRA INDIA ANNUAL REVIEW MEETING,
17TH-18TH MAY 2016, MUSSOORIE
Dr. Suchitra Lisam, National Health Programs Manager,
ADRA India
PRESENTATION OUTLINE
 PART I : POLIO AT A GLANCE
 PART II: GLOBAL POLIO UPDATES
 PART III: END GAME /ERADICATION TIMELINES
 PART IV: HEALTH SYSTEMS STRENGTHENING, POLIO
LEGACY IN INDIA
POLIO AT A GLANCE
PART I
POLIO AT A GLANCE
 Global Polio Eradication Initiatives (GPEI) is a public-
private partnership spearheaded by WHO, Rotary
International, US-CDC and UNICEF supported by key
partners including BMG Foundation and GAVI- the
vaccine alliance
 99% reduction in polio since 1988
 350,000 cases in 125 endemic countries in 1988
 74 cases in 2 endemic countries (Pakistan, Afghanistan) in
2015
 3 types of wild polio viruses (type 1, 2, 3)
 Wild poliovirus type 2 last detected in 1999, global
eradication declared in Sep 2015
POLIO AT A GLANCE –contd.
 Wild poliovirus type 3 not detected since Dec 2012
 2 types of vaccine- OPV and IPV
 More than 1.5 million childhood deaths prevented since
1988
 15 million cases averted since 1988
 More than 5000 m child immunized every year through
Routine Immunization and campaigns
 World Health Assembly has declared completion of polio
eradication as a programmatic emergency for global public
health.
Global polio updates and hss (1)
ELIMINATION STATUS
GLOBAL UPDATES
PART II
GLOBAL UPDATES (April’16)
 The Global Oral Polio Vaccine Switch, statistics on
WPV/cVDPV
 Immunization week
 Strategic Advisory Group of Experts on
Immunization (SAGE) Meeting
 Protecting Children in Countries Vulnerable to Polio
GLOBAL OPV SWITCH
GLOBAL OPV SWITCH-contd.
 From the 17 April to the 1 May, 155 countries and
territories participated in the historic trivalent to
bivalent oral polio vaccine switch, withdrawing the type
2 component of the vaccine to protect future
generations against circulating vaccine derived
polioviruses (cVDPV)
 Type 2 component of the oral polio vaccine (OPV) is
being removed from use from the trivalent to bivalent
oral polio vaccine to withdraw OPV in a phased
manner starting with type 2 component following the
eradication of wild poliovirus type 2 in September
2015

GLOBAL OPV SWITCH-contd.
 152 of 155 (98%) countries and territories have
stopped using the trivalent oral polio vaccine.
 Independent monitoring to ensure the switch goes
smoothly has begun in 126 of 153 countries (82%).
 The National Validation Committee has received switch
monitoring data from 16 of 153 countries.
 The WHO Regional Office has received the National
Validation Report from 10 countries.
GLOBAL OPV SWITCH-Contd.
WPV TYPE 1 & cVDPV -STATISTICS
Total
cases
Year-to-date 2016 Year-to-date 2015 Total in 2015
WPV cVDPV WPV cVDPV WPV cVDPV
Globally 12 3 23 1 74 32
- in
endemic
countries
12 0 23 1 74 3
- in non-
endemic
countries
0 3 0 0 0 29
Countries
Year-to-date 2016 Year-to-date 2015 Total in 2015 Onset of paralysis
of most recent case
WPV cVDPV WPV cVDPV WPV cVDPV WPV cVDPV
Afghanistan 4 0 1 0 20 0 27-Mar-16 NA
Pakistan 8 0 22 1 54 2 22-Mar-16 09-Feb-15
Guinea 0 0 0 0 0 7 NA 14-Dect-15
Lao PDR 0 3 0 0 0 8 NA 11-Jan-16
Madagascar 0 0 0 0 0 10 NA 22-Aug-15
Myanmar 0 0 0 0 0 2 NA 05-Oct-15
Nigeria 0 0 0 0 0 1 NA 16-May-15
Ukraine 0 0 0 0 0 2 NA 07-Jul-15
Global polio updates and hss (1)
Global polio updates and hss (1)
VULNERABLE COUNTRIES
 Polio remains endemic in two countries – Afghanistan and
Pakistan.
 Until poliovirus transmission is interrupted in these countries,
all countries remain at risk of importation of polio,
especially vulnerable countries with weak public health and
immunization services and travel or trade links to endemic
countries.
 Circulating vaccine-derived poliovirus is causing an outbreak
in Madagascar, Guinea and Ukraine.
Vulnerable countries : Cameroon, Equatorial Guinea,
Ethiopia, Iraq, Nigeria, Somalia, South Sudan and Syrian
Arab Republic.
POLIO IN NUMBERS-2016
 Wild poliovirus in 2016
- Global Total: 12 (23)
- Global WPV1: 12 (23)
- Global WPV3: 0 (0)
 Endemic: 12 (23)
-Afghanistan: 4 (1)
- Pakistan: 8 (22)
 Importation Countries: 0 (0)
Data as of 27 April 2016. Numbers in brackets represent data at this time in 2015
POLIO PUBLIC HEALTH EMERGENCY
 Temporary Recommendations to Reduce International Spread of
Poliovirus
 On 5 May 2014 the Director-General declared the international
spread of wild poliovirus in 2014 a Public Health Emergency of
International Concern (PHEIC) under the International Health
Regulations [IHR 2005], issued Temporary Recommendations to
reduce the international spread of wild poliovirus, and requested a
reassessment of this situation by the Emergency Committee every 3
months.
 The eight meeting of the Emergency Committee was held in
February 2016. Based on the committee’s advice and the reports
made by affected States Parties, the Director-General extended
the following Temporary Recommendations under the IHR (2005),
effective February 2016.
WORLD IMMUNIZATION WEEK
 In 2016(April) there
have only been 12
cases of polio, down
from 23 cases in the
same period for
2015.
 World Immunization
Week took place
between 24 – 30
April with the
theme “Close the
Immunization Gap”.
SAGE MEETING
 Recommends amendments of surveillance
case definition to include type 2 Sabin so
that all type 2 polioviruses will be notified
 Urges all countries to ensure completion of
phase I for all type 2 polioviruses, incl.
Sabin 2
 Endorsed the components of updated
MOV strategy to improve coverage,
equity and timeliness of vaccination
 Implementation research- more attention
 Immunization specific indicators to assess
progress towards <5 mortality target of
SDGs
PROTECTING CHILDREN IN VULNERABLE AREAS
 Keeping levels of immunity high by strengthening RI,
carrying out polio vaccination campaigns and
keeping vigilant surveillance systems for early
warning should the virus return is a top priority for
the GPEI.
 In Jordan, the Ministry of Health with the support of
WHO, UNICEF and partners, recently completed a
mass immunization campaign against polio,
reaching >1 million children <5 across the country
with OPV
KEY CHALLENGES
 Delivering quality health services.
 Improving reach, tracking missed children with OPV
in endemic countries
 Keeping up the pressure
 Despite the gains, there is still much to be done, not
only in Afghanistan and Pakistan but also in
countries with declining immunization rates. So long
as polio continues to circulate anywhere, children
everywhere are at risk.
END GAME PLAN/ ERADICATION TIMELINES
PART-III
Polio Eradication and Endgame Strategic Plan 2013–2018
IPV INTRODUCTION TIMELINES
POLIO ERADICATION TIMELINES
GPEI AND HEALTH SYSTEMS STRENGTHENING,
POLIO LEGACY-HEALTH SECTOR
PART -IV
BUILDING BLOCKS FRAMEWORKS OF HEALTH
SYSTEMS
POLIO LEGACY/SCOPE IN VPDs PROG
 Over the past 25 years, GPEI-funded personnel
and infrastructure have supported the distribution
of global and country health priorities including
 anti-measles vaccines
 vitamin A supplements
 anti-malarial bednets
 deworming pills
 surveillance for yellow fever and avian influenza
INDIA POLIO LEGACY
 Polio legacy in Action
 Mainstreaming critical polio eradication functions into
other priority health programmes
 Ensuring that the best practices and knowledge gained
over years are shared with other health initiatives
 Transitioning certain polio functional areas to
government counterparts
 Transitioning the capacities, processes and assets
created by the programme to support other vaccine
preventable diseases & strengthening health systems
TRANSITION OF ACTION
 Polio funded assets of WHO, UNICEF & CORE and others are
supporting RI strengthening activities in India
 Lessons learnt from polio/best practices being applied for RI &
control/elimination of VPDs
 Mission Indradhanush (MI) as a good example of government
led legacy in action for RI campaigns.
 Other transition areas- health, sanitation, nutrition, Ebola
 Transition/Legacy Plans are progressing and new initiatives to
bring it under one umbrella.
 Legacy Documentation is a major priority, ongoing
TRANSITION OF ACTION
 Transitioning assets/functions and applying lessons learned
 Strengthening routine immunization • Intensified RI monitoring –generating
data on quality of immunization, availability of vaccines/logistics, reasons
for low RI coverage and Zinc/ORS availability.
 Accountability through Task Forces, established in 36 states and 668
districts to review program data.
 Capacity building of frontline workers
 Advocacy and integrated communication including high risk areas in RI
session planning – 96% of high risk areas now included in RI micro plans.
 New vaccine introduction (Pentavalent; IPV, MR, Rotavirus) – Developing
field guidelines, training material and checklists for assessing preparedness
at district/state levels; conducting post-introduction and coverage
evaluations. Measles elimination and rubella control –
TRANSITION IN ACTION
 Supported catch-up campaigns covering approximately
119 million children. Visceral leishmaniasis (Kala Azar)
elimination – Monitoring indoor residual spraying;
contributing to national elimination strategy
development. VPD surveillance
 Coordinating validation of MNT elimination; capacity
building for lab personnel; launched lab supported
surveillance for diphtheria, pertussis and neonatal
tetanus with expansion planned in 2015
 AEFI surveillance – Assisting with updated guidelines;
training AEFI committees; supporting electronic case
reporting. Supporting international health programs –
Indian SMOs deployed to Nigeria, Sierra Leone and
Liberia in 2014-15.
LEGACY DOCUMENTATION
Completed
 Hosting Learning Missions – Afghanistan
and Pakistan
 Documents on Transition/Successful
Strategies in States
 Completed Legacy photographic book
 – demonstrating innovations/game
changers to triumph over polio
 Several films 7 documenting Social
Mobilization strategies, new PBS film
on transition polio to RI, short film
polio for RI.
 India Polio Learning Exchange website
Underway/planned 2015-2016
 Joint papers with WHO, GOI and
 partners under discussion
 SMNet Legacy Review (PWC) –
critical factors for success, SMNet
location/# for RI, and transition
options
 SMNet Impact on RI, Convergence,
Diarrhea morbidly and mortality
 IPV Introduction preparedness
 KAP
 Impact on the mobilizers themselves
Global polio updates and hss (1)
Global polio updates and hss (1)

More Related Content

PDF
Imperial College_Resilence_Strategies_beyond_COVID19_Pandemic_kaoutharlbiati_...
PDF
Fao lessons learned from HPAI outbreaks in Asia 2005 - 2011
PDF
Polio eradication & endgame stratplan 2013
PPTX
Polio End Game Strategy
PDF
Polio End Game Strategy _ India
PPTX
2016 Polio Eradication Initiative Update for Rotary Clubs in Raleigh / Durham
PPTX
Global Polio Eradication Initiative: implementing the Polio Eradication and E...
PDF
Global Immunization Newsletter 3/2012
Imperial College_Resilence_Strategies_beyond_COVID19_Pandemic_kaoutharlbiati_...
Fao lessons learned from HPAI outbreaks in Asia 2005 - 2011
Polio eradication & endgame stratplan 2013
Polio End Game Strategy
Polio End Game Strategy _ India
2016 Polio Eradication Initiative Update for Rotary Clubs in Raleigh / Durham
Global Polio Eradication Initiative: implementing the Polio Eradication and E...
Global Immunization Newsletter 3/2012

What's hot (19)

PDF
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...
PDF
Who europe update on polio eradication
PPT
Polio end game presentation
DOCX
Scaling up genomic sequencing in africa
PPTX
FMD-PCP workshop IZSLT - Update on the Implementation of the Global FMD Contr...
PPTX
Pentavalent: 1 vaccine to stop 5 diseases in 73 countries
PPTX
HIV in PREGNANCY
PPTX
Gavi - CEO Board Report 10 Dec 2014
PPTX
Strengthening immunisation systems to fight meningitis in Africa
PPTX
Antimicrobial Resistance A One Health Challenge for Joint Action
PPTX
Inactivated polio vaccine(IPV)
DOC
Fmd control strategies in kerala
PPTX
Draft global malaria technical strategy 2016–2030
PPTX
Lessons learnt from polio eradication in India
PDF
National Vaccine Policy 2011
PPTX
Dr Seth Berkley, Gavi CEO, Mid-term review presentation
PPTX
CEO Board report June 2016
PPTX
Immunization in India
PPTX
Gavi CEO Board update, June 2020
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...
Who europe update on polio eradication
Polio end game presentation
Scaling up genomic sequencing in africa
FMD-PCP workshop IZSLT - Update on the Implementation of the Global FMD Contr...
Pentavalent: 1 vaccine to stop 5 diseases in 73 countries
HIV in PREGNANCY
Gavi - CEO Board Report 10 Dec 2014
Strengthening immunisation systems to fight meningitis in Africa
Antimicrobial Resistance A One Health Challenge for Joint Action
Inactivated polio vaccine(IPV)
Fmd control strategies in kerala
Draft global malaria technical strategy 2016–2030
Lessons learnt from polio eradication in India
National Vaccine Policy 2011
Dr Seth Berkley, Gavi CEO, Mid-term review presentation
CEO Board report June 2016
Immunization in India
Gavi CEO Board update, June 2020
Ad

Similar to Global polio updates and hss (1) (20)

PPTX
National Immunization Program of Nepal from POSDCORB Perspectives
PPTX
6. Intestinal infections - 23.10.2023.pptx
PDF
Imperial college_kaouthar_Lbiati_11062020
PPTX
NVBDCP.ppt malaria mainly the cycle and control measures etc
PPTX
Presentation on pulse polio program pihu.pptx
PPTX
MiP ANC LRP 4 MIP PowerPoint 2021 update.pptx
PPTX
polio endgame strategy and ipv introduction
PPTX
NATIONAL IMMUNISATION PROGRAMME ...
PPTX
PPTX
Update on polio eradication in the Eastern Mediterranean Region
PPTX
Update on polio eradication in the Eastern Mediterranean Region
PPTX
Presentation (3) (1).pptx polio eradication programme
PDF
aj134e.pdf
PPTX
Universal vaccination programme
PPTX
Maintain polio free status
PDF
ICCM and Nutrition
DOCX
Malaria control
PPTX
WHO - AMR Global Overview and Action Plan
PPTX
Pulse Polio Program by Mujahid
PPTX
Ri in ut of puducherry success story of sepio dr.sudha goel
National Immunization Program of Nepal from POSDCORB Perspectives
6. Intestinal infections - 23.10.2023.pptx
Imperial college_kaouthar_Lbiati_11062020
NVBDCP.ppt malaria mainly the cycle and control measures etc
Presentation on pulse polio program pihu.pptx
MiP ANC LRP 4 MIP PowerPoint 2021 update.pptx
polio endgame strategy and ipv introduction
NATIONAL IMMUNISATION PROGRAMME ...
Update on polio eradication in the Eastern Mediterranean Region
Update on polio eradication in the Eastern Mediterranean Region
Presentation (3) (1).pptx polio eradication programme
aj134e.pdf
Universal vaccination programme
Maintain polio free status
ICCM and Nutrition
Malaria control
WHO - AMR Global Overview and Action Plan
Pulse Polio Program by Mujahid
Ri in ut of puducherry success story of sepio dr.sudha goel
Ad

More from Dr. Suchitra Lisam (6)

PDF
Water, sanitation and hygience (wash) in india 5th dec'16
PDF
Lisam-2014-Journal_of_Evidence-Based_Medicine
PDF
Global Polio Updates and HSS (1)
PPTX
Global polio updates and hss
PDF
Paper on case studies of health sub centers across states in india, global h...
PDF
Paper presentation on Rural Health Practitioners at GPH, Sri-Lanka 2014
Water, sanitation and hygience (wash) in india 5th dec'16
Lisam-2014-Journal_of_Evidence-Based_Medicine
Global Polio Updates and HSS (1)
Global polio updates and hss
Paper on case studies of health sub centers across states in india, global h...
Paper presentation on Rural Health Practitioners at GPH, Sri-Lanka 2014

Recently uploaded (20)

PPTX
Clinical approach and Radiotherapy principles.pptx
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
the psycho-oncology for psychiatrists pptx
PPTX
Cardiovascular - antihypertensive medical backgrounds
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
preoerative assessment in anesthesia and critical care medicine
PPTX
obstructive neonatal jaundice.pptx yes it is
PPTX
Morphology of Bacterial Cell for bsc sud
PPTX
Neuropathic pain.ppt treatment managment
PPTX
Anatomy and physiology of the digestive system
PDF
Cardiology Pearls for Primary Care Providers
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PPT
Infections Member of Royal College of Physicians.ppt
PPTX
Reading between the Rings: Imaging in Brain Infections
PPTX
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
PPTX
1. Basic chemist of Biomolecule (1).pptx
PPTX
ONCOLOGY Principles of Radiotherapy.pptx
Clinical approach and Radiotherapy principles.pptx
y4d nutrition and diet in pregnancy and postpartum
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
neurology Member of Royal College of Physicians (MRCP).ppt
the psycho-oncology for psychiatrists pptx
Cardiovascular - antihypertensive medical backgrounds
surgery guide for USMLE step 2-part 1.pptx
preoerative assessment in anesthesia and critical care medicine
obstructive neonatal jaundice.pptx yes it is
Morphology of Bacterial Cell for bsc sud
Neuropathic pain.ppt treatment managment
Anatomy and physiology of the digestive system
Cardiology Pearls for Primary Care Providers
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
CHEM421 - Biochemistry (Chapter 1 - Introduction)
Infections Member of Royal College of Physicians.ppt
Reading between the Rings: Imaging in Brain Infections
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
1. Basic chemist of Biomolecule (1).pptx
ONCOLOGY Principles of Radiotherapy.pptx

Global polio updates and hss (1)

  • 1. GLOBAL POLIO UPDATES, POLIO END GAME AND HEALTH SYSTEMS STRENGTHENING CGPP-ADRA INDIA ANNUAL REVIEW MEETING, 17TH-18TH MAY 2016, MUSSOORIE Dr. Suchitra Lisam, National Health Programs Manager, ADRA India
  • 2. PRESENTATION OUTLINE  PART I : POLIO AT A GLANCE  PART II: GLOBAL POLIO UPDATES  PART III: END GAME /ERADICATION TIMELINES  PART IV: HEALTH SYSTEMS STRENGTHENING, POLIO LEGACY IN INDIA
  • 3. POLIO AT A GLANCE PART I
  • 4. POLIO AT A GLANCE  Global Polio Eradication Initiatives (GPEI) is a public- private partnership spearheaded by WHO, Rotary International, US-CDC and UNICEF supported by key partners including BMG Foundation and GAVI- the vaccine alliance  99% reduction in polio since 1988  350,000 cases in 125 endemic countries in 1988  74 cases in 2 endemic countries (Pakistan, Afghanistan) in 2015  3 types of wild polio viruses (type 1, 2, 3)  Wild poliovirus type 2 last detected in 1999, global eradication declared in Sep 2015
  • 5. POLIO AT A GLANCE –contd.  Wild poliovirus type 3 not detected since Dec 2012  2 types of vaccine- OPV and IPV  More than 1.5 million childhood deaths prevented since 1988  15 million cases averted since 1988  More than 5000 m child immunized every year through Routine Immunization and campaigns  World Health Assembly has declared completion of polio eradication as a programmatic emergency for global public health.
  • 9. GLOBAL UPDATES (April’16)  The Global Oral Polio Vaccine Switch, statistics on WPV/cVDPV  Immunization week  Strategic Advisory Group of Experts on Immunization (SAGE) Meeting  Protecting Children in Countries Vulnerable to Polio
  • 11. GLOBAL OPV SWITCH-contd.  From the 17 April to the 1 May, 155 countries and territories participated in the historic trivalent to bivalent oral polio vaccine switch, withdrawing the type 2 component of the vaccine to protect future generations against circulating vaccine derived polioviruses (cVDPV)  Type 2 component of the oral polio vaccine (OPV) is being removed from use from the trivalent to bivalent oral polio vaccine to withdraw OPV in a phased manner starting with type 2 component following the eradication of wild poliovirus type 2 in September 2015 
  • 12. GLOBAL OPV SWITCH-contd.  152 of 155 (98%) countries and territories have stopped using the trivalent oral polio vaccine.  Independent monitoring to ensure the switch goes smoothly has begun in 126 of 153 countries (82%).  The National Validation Committee has received switch monitoring data from 16 of 153 countries.  The WHO Regional Office has received the National Validation Report from 10 countries.
  • 14. WPV TYPE 1 & cVDPV -STATISTICS Total cases Year-to-date 2016 Year-to-date 2015 Total in 2015 WPV cVDPV WPV cVDPV WPV cVDPV Globally 12 3 23 1 74 32 - in endemic countries 12 0 23 1 74 3 - in non- endemic countries 0 3 0 0 0 29
  • 15. Countries Year-to-date 2016 Year-to-date 2015 Total in 2015 Onset of paralysis of most recent case WPV cVDPV WPV cVDPV WPV cVDPV WPV cVDPV Afghanistan 4 0 1 0 20 0 27-Mar-16 NA Pakistan 8 0 22 1 54 2 22-Mar-16 09-Feb-15 Guinea 0 0 0 0 0 7 NA 14-Dect-15 Lao PDR 0 3 0 0 0 8 NA 11-Jan-16 Madagascar 0 0 0 0 0 10 NA 22-Aug-15 Myanmar 0 0 0 0 0 2 NA 05-Oct-15 Nigeria 0 0 0 0 0 1 NA 16-May-15 Ukraine 0 0 0 0 0 2 NA 07-Jul-15
  • 18. VULNERABLE COUNTRIES  Polio remains endemic in two countries – Afghanistan and Pakistan.  Until poliovirus transmission is interrupted in these countries, all countries remain at risk of importation of polio, especially vulnerable countries with weak public health and immunization services and travel or trade links to endemic countries.  Circulating vaccine-derived poliovirus is causing an outbreak in Madagascar, Guinea and Ukraine. Vulnerable countries : Cameroon, Equatorial Guinea, Ethiopia, Iraq, Nigeria, Somalia, South Sudan and Syrian Arab Republic.
  • 19. POLIO IN NUMBERS-2016  Wild poliovirus in 2016 - Global Total: 12 (23) - Global WPV1: 12 (23) - Global WPV3: 0 (0)  Endemic: 12 (23) -Afghanistan: 4 (1) - Pakistan: 8 (22)  Importation Countries: 0 (0) Data as of 27 April 2016. Numbers in brackets represent data at this time in 2015
  • 20. POLIO PUBLIC HEALTH EMERGENCY  Temporary Recommendations to Reduce International Spread of Poliovirus  On 5 May 2014 the Director-General declared the international spread of wild poliovirus in 2014 a Public Health Emergency of International Concern (PHEIC) under the International Health Regulations [IHR 2005], issued Temporary Recommendations to reduce the international spread of wild poliovirus, and requested a reassessment of this situation by the Emergency Committee every 3 months.  The eight meeting of the Emergency Committee was held in February 2016. Based on the committee’s advice and the reports made by affected States Parties, the Director-General extended the following Temporary Recommendations under the IHR (2005), effective February 2016.
  • 21. WORLD IMMUNIZATION WEEK  In 2016(April) there have only been 12 cases of polio, down from 23 cases in the same period for 2015.  World Immunization Week took place between 24 – 30 April with the theme “Close the Immunization Gap”.
  • 22. SAGE MEETING  Recommends amendments of surveillance case definition to include type 2 Sabin so that all type 2 polioviruses will be notified  Urges all countries to ensure completion of phase I for all type 2 polioviruses, incl. Sabin 2  Endorsed the components of updated MOV strategy to improve coverage, equity and timeliness of vaccination  Implementation research- more attention  Immunization specific indicators to assess progress towards <5 mortality target of SDGs
  • 23. PROTECTING CHILDREN IN VULNERABLE AREAS  Keeping levels of immunity high by strengthening RI, carrying out polio vaccination campaigns and keeping vigilant surveillance systems for early warning should the virus return is a top priority for the GPEI.  In Jordan, the Ministry of Health with the support of WHO, UNICEF and partners, recently completed a mass immunization campaign against polio, reaching >1 million children <5 across the country with OPV
  • 24. KEY CHALLENGES  Delivering quality health services.  Improving reach, tracking missed children with OPV in endemic countries  Keeping up the pressure  Despite the gains, there is still much to be done, not only in Afghanistan and Pakistan but also in countries with declining immunization rates. So long as polio continues to circulate anywhere, children everywhere are at risk.
  • 25. END GAME PLAN/ ERADICATION TIMELINES PART-III
  • 26. Polio Eradication and Endgame Strategic Plan 2013–2018
  • 29. GPEI AND HEALTH SYSTEMS STRENGTHENING, POLIO LEGACY-HEALTH SECTOR PART -IV
  • 30. BUILDING BLOCKS FRAMEWORKS OF HEALTH SYSTEMS
  • 31. POLIO LEGACY/SCOPE IN VPDs PROG  Over the past 25 years, GPEI-funded personnel and infrastructure have supported the distribution of global and country health priorities including  anti-measles vaccines  vitamin A supplements  anti-malarial bednets  deworming pills  surveillance for yellow fever and avian influenza
  • 32. INDIA POLIO LEGACY  Polio legacy in Action  Mainstreaming critical polio eradication functions into other priority health programmes  Ensuring that the best practices and knowledge gained over years are shared with other health initiatives  Transitioning certain polio functional areas to government counterparts  Transitioning the capacities, processes and assets created by the programme to support other vaccine preventable diseases & strengthening health systems
  • 33. TRANSITION OF ACTION  Polio funded assets of WHO, UNICEF & CORE and others are supporting RI strengthening activities in India  Lessons learnt from polio/best practices being applied for RI & control/elimination of VPDs  Mission Indradhanush (MI) as a good example of government led legacy in action for RI campaigns.  Other transition areas- health, sanitation, nutrition, Ebola  Transition/Legacy Plans are progressing and new initiatives to bring it under one umbrella.  Legacy Documentation is a major priority, ongoing
  • 34. TRANSITION OF ACTION  Transitioning assets/functions and applying lessons learned  Strengthening routine immunization • Intensified RI monitoring –generating data on quality of immunization, availability of vaccines/logistics, reasons for low RI coverage and Zinc/ORS availability.  Accountability through Task Forces, established in 36 states and 668 districts to review program data.  Capacity building of frontline workers  Advocacy and integrated communication including high risk areas in RI session planning – 96% of high risk areas now included in RI micro plans.  New vaccine introduction (Pentavalent; IPV, MR, Rotavirus) – Developing field guidelines, training material and checklists for assessing preparedness at district/state levels; conducting post-introduction and coverage evaluations. Measles elimination and rubella control –
  • 35. TRANSITION IN ACTION  Supported catch-up campaigns covering approximately 119 million children. Visceral leishmaniasis (Kala Azar) elimination – Monitoring indoor residual spraying; contributing to national elimination strategy development. VPD surveillance  Coordinating validation of MNT elimination; capacity building for lab personnel; launched lab supported surveillance for diphtheria, pertussis and neonatal tetanus with expansion planned in 2015  AEFI surveillance – Assisting with updated guidelines; training AEFI committees; supporting electronic case reporting. Supporting international health programs – Indian SMOs deployed to Nigeria, Sierra Leone and Liberia in 2014-15.
  • 36. LEGACY DOCUMENTATION Completed  Hosting Learning Missions – Afghanistan and Pakistan  Documents on Transition/Successful Strategies in States  Completed Legacy photographic book  – demonstrating innovations/game changers to triumph over polio  Several films 7 documenting Social Mobilization strategies, new PBS film on transition polio to RI, short film polio for RI.  India Polio Learning Exchange website Underway/planned 2015-2016  Joint papers with WHO, GOI and  partners under discussion  SMNet Legacy Review (PWC) – critical factors for success, SMNet location/# for RI, and transition options  SMNet Impact on RI, Convergence, Diarrhea morbidly and mortality  IPV Introduction preparedness  KAP  Impact on the mobilizers themselves